Biomarin Pharmaceutical Inc Q2 2023 Earnings Call Summary - Thomson StreetEvents

Biomarin Pharmaceutical Inc Q2 2023 Earnings Call Summary

Biomarin Pharmaceutical Inc Q2 2023 Earnings Call Summary - Thomson StreetEvents
Biomarin Pharmaceutical Inc Q2 2023 Earnings Call Summary
Published Jul 31, 2023
Published Jul 31, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of BMRN.OQ earnings conference call or presentation 31-Jul-23 8:30pm GMT

  
Report Type:

Brief

Source:
Company:
Biomarin Pharmaceutical Inc
Ticker
BMRN.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Biomarin Pharmaceutical Inc R&D Day Summary – 2023-09-12 – US$ 54.00 – Edited Brief of BMRN.OQ corporate analyst meeting</ 12-Sep-23 12:00pm GMT

Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference Summary – 2023-09-11 – US$ 54.00 – Edited Brief of BMRN.OQ presentation 11-Sep-23 2:00pm GMT

Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-11 – US$ 54.00 – Edited Transcript of BMRN.OQ presentation 11-Sep-23 2:00pm GMT

Biomarin Pharmaceutical Inc at Citi BioPharma Conference Transcript – 2023-09-06 – US$ 54.00 – Edited Transcript of BMRN.OQ presentation 6-Sep-23 7:30pm GMT

Biomarin Pharmaceutical Inc Q2 2023 Earnings Call Transcript – 2023-07-31 – US$ 54.00 – Edited Transcript of BMRN.OQ earnings conference call or presentation 31-Jul-23 8:30pm GMT

Biomarin Pharmaceutical Inc U.S. Food and Drug Administration Approves ROCTAVIAN Call Summary – 2023-06-29 – US$ 54.00 – Edited Brief of BMRN.OQ conference call or presentation 29-Jun-23 8:30pm GMT

Biomarin Pharmaceutical Inc U.S. Food and Drug Administration Approves ROCTAVIAN Call Transcript – 2023-06-29 – US$ 54.00 – Edited Transcript of BMRN.OQ conference call or presentation 29-Jun-23 8:30pm GMT

Biomarin Pharmaceutical Inc at Bank of America Global Healthcare Conference Summary – 2023-05-10 – US$ 54.00 – Edited Brief of BMRN.OQ presentation 10-May-23 10:40pm GMT

Biomarin Pharmaceutical Inc at Bank of America Global Healthcare Conference Transcript – 2023-05-10 – US$ 54.00 – Edited Transcript of BMRN.OQ presentation 10-May-23 10:40pm GMT

Biomarin Pharmaceutical Inc Q1 2023 Earnings Call Summary – 2023-04-26 – US$ 54.00 – Edited Brief of BMRN.OQ earnings conference call or presentation 26-Apr-23 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Biomarin Pharmaceutical Inc Q2 2023 Earnings Call Summary" Jul 31, 2023. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Biomarin-Pharmaceutical-Inc-Earnings-Call-B15659449>
  
APA:
Thomson StreetEvents. (2023). Biomarin Pharmaceutical Inc Q2 2023 Earnings Call Summary Jul 31, 2023. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Biomarin-Pharmaceutical-Inc-Earnings-Call-B15659449>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.